SCHEMBL5338619

SCHEMBL5338619

O=c1oc2c(O)c(O)ccc2c(O)c1C1c2c(c3ccc(O)c(O)c3oc2=O)OC1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKLR P30613 1/20 0.47
GALNT2 Q10471 1/20 0.47
GALNT1 Q10472 1/20 0.47
GALNT3 Q14435 1/20 0.47
GALNT10 Q86SR1 1/20 0.47
GALNT13 Q8IUC8 1/20 0.47
GALNT6 Q8NCL4 1/20 0.47
GALNT14 Q96FL9 1/20 0.47
ATP1A1 P05023 3/20 0.45
ATP1B1 P05026 3/20 0.45
ATP1A3 P13637 3/20 0.45
ATP1B2 P14415 3/20 0.45
ATP1A2 P50993 3/20 0.45
ATP1B3 P54709 3/20 0.45
FXYD2 P54710 3/20 0.45
ATP1A4 Q13733 3/20 0.45
NUDT1 P36639 1/20 0.45
MET P08581 1/20 0.42
MCL1 Q07820 4/20 0.39
KDM4E B2RXH2 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5337618 0.90 ESR2 (0.49) KDM4EMAPK1ALDH1A1GAALMNA
SCHEMBL5345493 0.84 NQO1 (0.51) MCL1KDM4EMAPK1ALDH1A1GAA
SCHEMBL5344941 0.83 ABCG2 (0.42) MCL1KDM4EMAPTMAPK1ALDH1A1
SCHEMBL5338654 0.82 ESR2 (0.38) MCL1KDM4EESR2
SCHEMBL6365692 0.82 PKLR (0.43) PKLRGALNT2GALNT1GALNT3GALNT10
SCHEMBL5340558 0.80 GABRA1 (0.34) MAPTPKMMEN1KMT2A
SCHEMBL5341632 0.79 HIF1A (0.33) CYP3A4LMNABLMHPGDCYP2C9
SCHEMBL5345122 0.77 PDE4D (0.40) KDM4EMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5342546 0.76 NQO1 (0.49) PKLRKDM4EMAPTALDH1A1ALOX15
SCHEMBL5352117 0.75 NQO1 (0.53) KDM4EMAPTMAPK1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060148890-A1 Substituted furochromene compounds of antiinflammatory action PLIVA-LSTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US claimed
EP-1648901-A1 SUBSTITUTED FUROCHROMENE COMPOUNDS OF ANTIINFLAMMATORY ACTION PLIVA-ISTRAZIVACKI INSTITUT d.o.o. (HR) 2006-04-26 EP claimed
WO-2005010006-A1 SUBSTITUTED FUROCHROMENE COMPOUNDS OF ANTIINFLAMMATORY ACTION PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2005-02-03 WO claimed
US-7208518-B2 Substituted furochromene compounds of antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2007-04-24 US disclosed
US-7208518-B2 Substituted furochromene compounds of antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2007-04-24 US disclosed
US-7208518-B2 Substituted furochromene compounds of antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2007-04-24 US disclosed
US-20060148890-A1 Substituted furochromene compounds of antiinflammatory action PLIVA-LSTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148890-A1 Substituted furochromene compounds of antiinflammatory action LTC4S, CYP11B2, CYP11B1 PKLR 1510/4885GALNT2 1512/4885GALNT1 1254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.